Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Clinical TrialBusiness Wire • 01/25/22
Arcturus Therapeutics' COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody ResponsesBenzinga • 01/24/22
Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 and Several VariantsBusiness Wire • 01/24/22
Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 and ARCT-165 Clinical TrialsBusiness Wire • 12/16/21
Is the Options Market Predicting a Spike in Arcturus Therapeutics (ARCT) Stock?Zacks Investment Research • 12/10/21
Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare ConferenceBusiness Wire • 11/22/21
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/09/21
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/09/21
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline ProgressBusiness Wire • 11/08/21
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to DeclineZacks Investment Research • 11/01/21
Arcturus Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on November 8, 2021Business Wire • 10/25/21
3 Beaten-Down Stocks Cathie Wood Is Buying That Wall Street Thinks Will SkyrocketThe Motley Fool • 10/19/21
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 3b Study for ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of ConcernBusiness Wire • 10/12/21
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine CollaborationBusiness Wire • 09/22/21
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of ConcernBusiness Wire • 09/22/21
Arcturus Therapeutics to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021Business Wire • 09/08/21
Arcturus Therapeutics to Present at Upcoming Investor and Scientific ConferencesBusiness Wire • 09/07/21
Tuesday Afternoon Analyst Upgrades and Downgrades: SmileDirectClub, Squarespace, Victoria's Secret and More24/7 Wall Street • 08/10/21